ASMB logo

ASMB
Assembly Biosciences Inc

4,179
Mkt Cap
$448.91M
Volume
78,969.00
52W High
$39.71
52W Low
$10.41
PE Ratio
-15.39
ASMB Fundamentals
Price
$28.33
Prev Close
$28.30
Open
$28.33
50D MA
$28.55
Beta
1.10
Avg. Volume
75,924.92
EPS (Annual)
-$0.5461
P/B
2.17
Rev/Employee
$990,452.06
$135.81
Loading...
Loading...
News
all
press releases
Assembly Biosciences, Inc. (NASDAQ:ASMB) Receives Consensus Rating of "Moderate Buy" from Brokerages
Assembly Biosciences, Inc. (NASDAQ:ASMB - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seven ratings firms that are presently covering the company, Marketbeat...
MarketBeat·12d ago
News Placeholder
More News
News Placeholder
Assembly Biosciences (NASDAQ:ASMB) Price Target Raised to $43.00 at Guggenheim
Guggenheim raised their price objective on shares of Assembly Biosciences from $39.00 to $43.00 and gave the company a "buy" rating in a research note on Monday...
MarketBeat·17d ago
News Placeholder
HC Wainwright Analysts Lower Earnings Estimates for ASMB
Assembly Biosciences, Inc. (NASDAQ:ASMB - Free Report) - HC Wainwright decreased their Q1 2026 earnings per share (EPS) estimates for Assembly Biosciences in a report released on Thursday, March...
MarketBeat·25d ago
News Placeholder
Wall Street Zen Upgrades Assembly Biosciences (NASDAQ:ASMB) to Strong-Buy
Wall Street Zen upgraded shares of Assembly Biosciences from a "buy" rating to a "strong-buy" rating in a research report on Sunday...
MarketBeat·26d ago
News Placeholder
Q1 Earnings Estimate for ASMB Issued By HC Wainwright
Assembly Biosciences, Inc. (NASDAQ:ASMB - Free Report) - Analysts at HC Wainwright issued their Q1 2027 earnings estimates for Assembly Biosciences in a report issued on Thursday, March 26th. HC Wainwright analyst P. Trucchio expects that the biopharmaceutical company will earn ($0.16) per share for...
MarketBeat·27d ago
News Placeholder
Assembly Biosciences (NASDAQ:ASMB) Receives "Buy" Rating from HC Wainwright
HC Wainwright reaffirmed a "buy" rating and set a $50.00 price objective on shares of Assembly Biosciences in a research report on Thursday...
MarketBeat·28d ago
News Placeholder
Assembly Biosciences (NASDAQ:ASMB) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Assembly Biosciences from a "hold" rating to a "buy" rating in a research report on Saturday...
MarketBeat·1mo ago
News Placeholder
Assembly Biosciences (NASDAQ:ASMB) Announces Quarterly Earnings Results, Beats Estimates By $2.99 EPS
Assembly Biosciences (NASDAQ:ASMB - Get Free Report) released its quarterly earnings data on Thursday. The biopharmaceutical company reported $2.48 EPS for the quarter, topping analysts' consensus estimates of ($0.51) by $2.99. The company had revenue of $42.47 million for the quarter, compared to...
MarketBeat·1mo ago
News Placeholder
Assembly Biosciences (ASMB) Q4 Earnings and Revenues Top Estimates
Assembly Biosciences (ASMB) delivered earnings and revenue surprises of +586.28% and +300.65%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Assembly Biosciences, Inc. (NASDAQ:ASMB) Given Average Recommendation of "Moderate Buy" by Analysts
Shares of Assembly Biosciences, Inc. (NASDAQ:ASMB - Get Free Report) have earned a consensus rating of "Moderate Buy" from the seven analysts that are covering the company, MarketBeat reports. One...
MarketBeat·1mo ago
<
1
2
...
>

Latest ASMB News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.